H.B. 309

1

CONTROLLED SUBSTANCES ACT
2 AMENDMENTS
3 1998 GENERAL SESSION
4 STATE OF UTAH
5 Sponsor: Patrice Arent
6 AN ACT RELATING TO CONTROLLED SUBSTANCES; AMENDING THE CONTROLLED
7 SUBSTANCES ACT TO REFLECT THE FEDERAL CODE IN SCHEDULES I THROUGH
8 V; AND PROVIDING AN INFORMATIONAL NOTE.
9 This act affects sections of Utah Code Annotated 1953 as follows:
10 AMENDS:
11 58-37-4, as last amended by Chapter 64, Laws of Utah 1997
12 This act enacts uncodified material.
13 Be it enacted by the Legislature of the state of Utah:
14 Section 1. Section 58-37-4 is amended to read:
15 58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
16 required -- Specific substances included in schedules.
17 (1) There are established five schedules of controlled substances known as Schedules I,
18 II, III, IV, and V which shall consist of substances listed in this section.
19 (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the
20 official name, common or usual name, chemical name, or brand name designated:
21 (a) Schedule I:
22 (i) Unless specifically excepted or unless listed in another schedule, any of the following
23 opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when
24 the existence of the isomers, esters, ethers, and salts is possible within the specific chemical
25 designation:
26 (A) [Acetyl-alphamethylfentanyl] Acetyl-alpha-methylfentanyl
27 (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);

1 (B) Acetylmethadol;
2 (C) Allylprodine;
3 (D) Alphacetylmethadol, [(]except levo-alphacetylmethadol also known as
4 levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM[)];
5 (E) Alphameprodine;
6 (F) Alphamethadol;
7 [(G) Alpha-methiofentanyl;]
8 [(H)] (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
9 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine);
10 (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
11 piperidinyl]-N-phenylpropanamide);
12 (I) Benzethidine;
13 [(L)] (J) Betacetylmethadol;
14 (K) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
15 piperidinyl]-N-phenylpropanamide);
16 [(J)] (L) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
17 phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
18 (M) Betameprodine;
19 (N) Betamethadol;
20 (O) Betaprodine;
21 [(P) Cathinone;]
22 [(Q)] (P) Clonitazene;
23 [(R)] (Q) Dextromoramide;
24 [(S)] (R) Diampromide;
25 [(T)] (S) Diethylthiambutene;
26 [(U)] (T) Difenoxin;
27 [(V)] (U) Dimenoxadol;
28 [(W)] (V) Dimepheptanol;
29 [(X)] (W) Dimethylthiambutene;
30 [(Y)] (X) Dioxaphetyl butyrate;
31 [(Z)] (Y) Dipipanone;

- 2 -

1 [(AA)] (Z) Ethylmethylthiambutene;
2 [(BB)] (AA) Etonitazene;
3 [(CC)] (BB) Etoxeridine;
4 [(DD)] (CC) Furethidine;
5 [(EE)] (DD) Hydroxypethidine;
6 [(FF)] (EE) Ketobemidone;
7 [(GG)] (FF) Levomoramide;
8 [(HH)] (GG) Levophenacylmorphan;
9 [(II) Methcathinone;]
10 [(JJ)] (HH) Morpheridine;
11 [(KK)] (II) [Mppp (l-methyl-4-phenyl-4-propionoxpipiridine)] MPPP
12 (1-methyl-4-phenyl-4-propionoxypiperidine);
13 [(LL)] (JJ) Noracymethadol;
14 [(MM)] (KK) Norlevorphanol;
15 [(NN)] (LL) Normethadone;
16 [(OO)] (MM) Norpipanone;
17 [(PP)] (NN) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
18 propanamide;
19 [(QQ)] (OO) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
20 [(RR)] (PP) Phenadoxone;
21 [(SS)] (QQ) Phenampromide;
22 [(TT)] (RR) Phenomorphan;
23 [(UU)] (SS) Phenoperidine;
24 [(VV)] (TT) Piritramide;
25 [(WW)] (UU) Proheptazine;
26 [(XX)] (VV) Properidine;
27 [(YY)] (WW) Propiram;
28 [(ZZ)] (XX) Racemoramide;
29 [(AAA)] (YY) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
30 [(BBB)] (ZZ) Tilidine;
31 [(CCC)] (AAA) Trimeperidine;

- 3 -

1 [(DDD) 3-menthylthiofentanyl; and]
2 [(EEE)] (BBB) 3-methylfentanyl[.], including the optical and geometric isomers
3 (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
4 (CCC) 3-methylthiofentanyl
5 (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
6 (ii) Unless specifically excepted or unless listed in another schedule, any of the following
7 opium derivatives, their salts, isomers, and salts of isomers when the existence of the salts,
8 isomers, and salts of isomers is possible within the specific chemical designation:
9 (A) Acetorphine;
10 (B) Acetyldihydrocodeine;
11 (C) Benzylmorphine;
12 (D) Codeine methylbromide;
13 (E) Codeine-N-Oxide;
14 (F) Cyprenorphine;
15 (G) Desomorphine;
16 (H) Dihydromorphine;
17 (I) Drotebanol;
18 (J) Etorphine (except hydrochloride salt);
19 (K) Heroin;
20 (L) Hydromorphinol;
21 (M) Methyldesorphine;
22 (N) Methylhydromorphine;
23 (O) Morphine methylbromide;
24 (P) Morphine methylsulfonate;
25 (Q) Morphine-N-Oxide;
26 (R) Myrophine;
27 (S) Nicocodeine;
28 (T) Nicomorphine;
29 (U) Normorphine;
30 (V) Pholcodine; and
31 (W) Thebacon.

- 4 -

1 (iii) Unless specifically excepted or unless listed in another schedule, any material,
2 compound, mixture, or preparation which contains any quantity of the following hallucinogenic
3 substances, or which contains any of their salts, isomers, and salts of isomers when the existence
4 of the salts, isomers, and salts of isomers is possible within the specific chemical designation; as
5 used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and geometric
6 isomers:
7 (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
8 .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
9 [(A)] (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
10 4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
11 (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
12 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
13 [(B)] (D) 2,5-dimethoxyamphetamine, some trade or other names:
14 2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
15 (E) 2,5-dimethoxy-4-ethylamphet-amine, some trade or other names: DOET;
16 (F) 4-methoxyamphetamine, some trade or other names:
17 4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
18 [(E)] (G) 5-methoxy-3,4-methylenedioxy amphetamine;
19 [(K)] (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
20 4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
21 [(C)] (I) 3,4-methylenedioxy amphetamine;
22 [(D) 3,4-methylenedioxy methamphetamine (MDMA);]
23 (J) 3,4-methylenedioxymethamphetamine (MDMA);
24 (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
25 alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
26 (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
27 N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
28 [(G)] (M) 3,4,5-trimethoxy amphetamine;
29 [(H)] (N) Bufotenine, some trade and other names: 3-(.
30 -Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
31 N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;

- 5 -

1 [(I)] (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
2 [(J)] (P) Dimethyltryptamine, some trade or other names: DMT;
3 [(L)] (Q) Ibogaine, some trade and other names:
4 7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
5 [5,4-b] indole; Tabernanthe iboga;
6 [(M)] (R) Lysergic acid diethylamide;
7 [(N)] (S) [Marijuana] Marihuana;;
8 [(O)] (T) Mescaline;
9 [(P)] (U) Parahexyl, some trade or other names:
10 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
11 [(Q)] (V) Peyote, meaning all parts of the plant presently classified botanically as
12 Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any
13 part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of
14 such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
15 [(R)] (W) N-ethyl-3-piperidyl benzilate;
16 [(S)] (X) N-methyl-3-piperidyl benzilate;
17 [(T)] (Y) Psilocybin;
18 [(U)] (Z) Psilocyn;
19 [(V)] (AA) Tetrahydrocannabinols, synthetic equivalents of the substances contained in
20 the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
21 and their isomers with similar chemical structure and pharmacological activity such as the
22 following: .1 cis or trans tetrahydrocannabinol, and their optical isomers .6 cis or trans
23 tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its
24 optical isomers, and since nomenclature of these substances is not internationally standardized,
25 compounds of these structures, regardless of numerical designation of atomic positions covered;
26 [(W)] (BB) Ethylamine analog of phencyclidine, some trade or other names:
27 N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
28 N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
29 [(X)] (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
30 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
31 [(Y) 1-1-(2-Thieny) Cyclohexyl Pyrrolidine; and]

- 6 -

1 [(Z)] (DD) Thiophene analog of phencyclidine[.], some trade or other names:
2 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
3 (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
4 (iv) Unless specifically excepted or unless listed in another schedule, any material
5 compound, mixture, or preparation which contains any quantity of the following substances having
6 a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers
7 when the existence of the salts, isomers, and salts of isomers is possible within the specific
8 chemical designation:
9 (A) Mecloqualone; and
10 (B) Methaqualone.
11 (v) Any material, compound, mixture, or preparation containing any quantity of the
12 following substances having a stimulant effect on the central nervous system, including their salts,
13 isomers, and salts of isomers:
14 (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
15 4,5-dihydro-5-phenly-2-oxazolamine;
16 (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
17 alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
18 [(A)] (C) Fenethylline;
19 (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
20 alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
21 alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
22 methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
23 optical isomers;
24 [(B) 4-Methylaminorex; and]
25 (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
26 [(C)] (F) N-ethylamphetamine; and
27 (G) N,N-dimethylamphetamine, also known as N,N-alpha-trimethyl-benzeneethanamine;
28 N,N-alpha-trimethylphenethylamine.
29 (vi) Any material, compound, mixture, or preparation which contains any quantity of the
30 following substances, including their optical isomers, salts, and salts of isomers, subject to
31 temporary emergency scheduling:

- 7 -

1 (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
2 (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
3 (b) Schedule II:
4 (i) Unless specifically excepted or unless listed in another schedule, any of the following
5 substances whether produced directly or indirectly by extraction from substances of vegetable
6 origin, or independently by means of chemical synthesis, or by a combination of extraction and
7 chemical synthesis:
8 (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
9 opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
10 and their respective salts, but including:
11 (I) Raw opium;
12 (II) Opium extracts;
13 (III) Opium fluid [extracts];
14 (IV) Powdered opium;
15 (V) Granulated opium;
16 (VI) Tincture of opium;
17 (VII) Codeine;
18 (VIII) Ethylmorphine;
19 (IX) Etorphine hydrochloride;
20 (X) Hydrocodone;
21 (XI) Hydromorphone;
22 (XII) Metopon;
23 (XIII) Morphine;
24 (XIV) Oxycodone;
25 (XV) Oxymorphone; and
26 (XVI) Thebaine;
27 (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
28 identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
29 substances may not include the isoquinoline alkaloids of opium;
30 (C) Opium poppy and poppy straw;
31 (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any

- 8 -

1 salt, compound, derivative, or preparation which is chemically equivalent or identical with any of
2 these substances, and includes cocaine and ecgonine, [its] their salts, isomers, derivatives, and salts
3 of isomers and derivatives, whether derived from the coca plant or synthetically produced, except
4 the substances may not include decocainized coca leaves or extraction of coca leaves, which
5 extractions do not contain cocaine or ecgonine; and
6 (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
7 liquid, solid, or powder form which contains the [phenanthrine] phenanthrene alkaloids of the
8 opium poppy.
9 (ii) Unless specifically excepted or unless listed in another schedule, any of the following
10 opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when
11 the existence of the isomers, esters, ethers, and salts is possible within the specific chemical
12 designation, except dextrorphan and levopropoxyphene:
13 [(B)] (A) Alfentanil;
14 [(A)] (B) Alphaprodine;
15 (C) Anileridine;
16 (D) Bezitramide;
17 (E) Bulk dextropropoxyphene (nondosage forms);
18 (F) Carfentanil;
19 (G) Dihydrocodeine;
20 (H) Diphenoxylate;
21 (I) Fentanyl;
22 (J) Isomethadone;
23 [(L)] (K) Levo-alphacetylmethadol, [(]some other names: levo-alpha-acetylmethadol,
24 levomethadyl acetate, or LAAM[)];
25 [(K)] (L) Levomethorphan;
26 (M) Levorphanol;
27 (N) Metazocine;
28 (O) Methadone;
29 (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
30 [(Q) Methyl-Fentanyl;]
31 [(R)] (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1,

- 9 -

1 1-diphenylpropane-carboxylic acid;
2 [(S)] (R) Pethidine (meperidine);
3 [(T)] (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
4 [(U)] (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
5 [(V)] (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
6 [(W)] (V) Phenazocine;
7 [(X)] (W) Piminodine;
8 [(Y)] (X) Racemethorphan;
9 [(Z)] (Y) Racemorphan; [and]
10 (Z) Remifentanil; and
11 (AA) Sufentanil.
12 (iii) Unless specifically excepted or unless listed in another schedule, any material,
13 compound, mixture, or preparation which contains any quantity of the following substances having
14 a stimulant effect on the central nervous system:
15 (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
16 (B) Methamphetamine, its salts, isomers, and salts of its isomers;
17 (C) Phenmetrazine and its salts; and
18 (D) Methylphenidate.
19 (iv) Unless specifically excepted or unless listed in another schedule, any material,
20 compound, mixture, or preparation which contains any quantity of the following substances having
21 a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers
22 when the existence of the salts, isomers, and salts of isomers is possible within the specific
23 chemical designation:
24 (A) Amobarbital;
25 [(B) N,N,Dimethylamphetamine;]
26 [(C)] (B) Glutethimide;
27 [(D)] (C) Pentobarbital;
28 [(E)] (D) Phencyclidine;
29 [(F)] (E) Phencyclidine immediate precursors: [1-phenyl-cyclohexylamine]
30 1-phenylcyclohexylamine and 1-piperidinocyclohexanecarbonitrile (PCC); and
31 [(G)] (F) Secobarbital.

- 10 -

1 (v) Unless specifically excepted or unless listed in another schedule, any material,
2 compound, mixture, or preparation which contains any quantity of Phenylacetone.
3 Some of these substances may be known by trade or other names: phenyl-2-propanone,
4 P2P; benzyl methyl ketone, methyl benzyl ketone.
5 (vi) (A) [Dranabinol] Dronabinol (synthetic) in sesame oil and encapsulated in a soft
6 gelatin capsule in a [Fulnal] U.S. Food and Drug Administration approved drug product, some
7 other names for dronabinol:
8 (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
9 (-)-delta-9-(trans)-tetrahydrocannabinol; and
10 (B) [Nabinol] Nabilone, another name for nabilone:
11 (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
12 6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
13 (c) Schedule III:
14 (i) Unless specifically excepted or unless listed in another schedule, any material,
15 compound, mixture, or preparation which contains any quantity of the following substances having
16 a stimulant effect on the central nervous system, including its salts, isomers whether optical,
17 position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts
18 of isomers is possible within the specific chemical designation:
19 (A) Those compounds, mixtures, or preparations in dosage unit form containing any
20 stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were listed
21 on August 25, 1971, as excepted compounds under Section [308.32] 1308.32 of Title 21 of the
22 Code of Federal Regulations, and any other drug of the quantitive composition shown in that list
23 for those drugs or which is the same except that it contains a lesser quantity of controlled
24 substances;
25 (B) Benzphetamine;
26 (C) Chlorphentermine;
27 (D) Clortermine; and
28 [(E) Mazindol; and]
29 [(F)] (E) Phendimetrazine.
30 (ii) Unless specifically excepted or unless listed in another schedule, any material,
31 compound, mixture, or preparation which contains any quantity of the following substances having

- 11 -

1 a depressant effect on the central nervous system:
2 (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
3 pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients which
4 are not listed in any schedule;
5 (B) Any suppository dosage form containing amobarbital, secobarbital, or pentobarbital,
6 or any salt of any of these drugs which is approved by the Food and Drug Administration for
7 marketing only as a suppository;
8 (C) Any substance which contains any quantity of a derivative of barbituric acid or any
9 salt of any of them;
10 (D) [Chorhexadol] Chlorhexadol;
11 (E) Lysergic acid;
12 (F) Lysergic acid amide;
13 (G) Methyprylon;
14 (H) Sulfondiethylmethane;
15 (I) Sulfonethylmethane;
16 (J) Sulfonmethane; and
17 (K) Tiletamine and zolazepam or any of their salts, some trade or other names for a
18 tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
19 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
20 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
21 flupyrazapon.
22 (iii) Nalorphine.
23 (iv) Unless specifically excepted or unless listed in another schedule, any material,
24 compound, mixture, or preparation containing limited quantities of any of the following narcotic
25 drugs, or [any] their salts [of any of them] calculated as the free anhydrous base or alkaloid:
26 (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
27 per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
28 (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
29 per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic
30 amounts;
31 (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more

- 12 -

1 than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid
2 of opium;
3 (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
4 than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
5 recognized therapeutic amounts;
6 (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
7 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
8 therapeutic amounts;
9 (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than
10 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized
11 therapeutic amounts;
12 (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
13 more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
14 recognized therapeutic amounts;
15 (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
16 one or more active, non-narcotic ingredients in recognized therapeutic amounts.
17 (v) Unless specifically excepted or unless listed in another schedule, anabolic steroids
18 including any of the following or any isomer, ester, salt, or derivative of the following that [acts
19 in the same manner on the human body] promotes muscle growth:
20 (A) Boldenone;
21 (B) Chlorotestosterone (4-chlortestosterone);
22 [(A)] (C) Clostebol;
23 [(B) Chorionic gonadotropin;]
24 [(C) Dehydroclormethyltestosterone;]
25 (D) Dehydrochlormethyltestosterone;
26 (E) Dihydrotestosterone (4-dihydrotestosterone);
27 (F) Drostanolone;
28 [(D)] (G) Ethylestrenol;
29 [(E) Fluxymesterone;]
30 (H) Fluoxymesterone;
31 (I) Formebulone (formebolone);

- 13 -

1 [(F)] (J) Mesterolone;
2 [(G) Methandrenone;]
3 (K) Methandienone;
4 (L) Methandranone;
5 (M) Methandriol;
6 [(H)] (N) Methandrostenolone;
7 [(I)] (O) Methenolone;
8 [(J)] (P) Methyltestosterone[, except when combined with esterified estrogens];
9 (Q) Mibolerone;
10 [(K)] (R) Nandrolone [decanoate];
11 [(L) Nandrolone phenpropionate;]
12 [(M)] (S) Norethandrolone;
13 [(N)] (T) Oxandrolone;
14 [(O)] (U) Oxymesterone;
15 [(P)] (V) Oxymetholone;
16 (W) Stanolone;
17 [(Q)] (X) Stanozolol; [and]
18 (Y) Testolactone;
19 [(R)] (Z) Testosterone [propionate.]; and
20 (AA) Trenbolone.
21 Anabolic steroids expressly intended for administration through implants to cattle or other
22 nonhuman species, and approved by the [Food and Drug Administration] Secretary of Health and
23 Human Services for use, may not be classified as a controlled substance.
24 (d) Schedule IV:
25 (i) Unless specifically excepted or unless listed in another schedule, any material,
26 compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less
27 than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them;
28 (ii) Unless specifically excepted or unless listed in another schedule, any material,
29 compound, mixture, or preparation which contains any quantity of the following substances,
30 including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts
31 of isomers is possible within the specific chemical designation:

- 14 -

1 (A) Alprazolam;
2 (B) Barbital;
3 (C) Bromazepam;
4 (D) Butorphanol;
5 [(D)] (E) Camazepam;
6 [(E)] (F) Chloral betaine;
7 [(F)] (G) Chloral hydrate;
8 [(G)] (H) Chlordiazepoxide;
9 [(H)] (I) Clobazam;
10 [(I)] (J) Clonazepam;
11 [(J)] (K) Clorazepate;
12 [(K)] (L) Clotiazepam;
13 [(L)] (M) Cloxazolam;
14 [(M)] (N) Delorazepam;
15 [(N)] (O) Diazepam;
16 [(O)] (P) Estazolam;
17 [(P)] (Q) Ethchlorvynol;
18 [(Q)] (R) Ethinamate;
19 [(R)] (S) Ethyl loflazepate;
20 [(S)] (T) Fludiazepam;
21 [(T)] (U) Flunitrazepam;
22 [(U)] (V) Flurazepam;
23 [(V)] (W) Halazepam;
24 [(W)] (X) Haloxazolam;
25 [(X)] (Y) Ketazolam;
26 [(Y)] (Z) Loprazolam;
27 [(Z)] (AA) Lorazepam;
28 (BB) Lormetazepam;
29 [(AA)] (CC) Mebutamate;
30 [(BB)] (DD) Medazepam;
31 [(CC) Medazolam;]

- 15 -

1 (EE) Meprobamate;
2 [(DD)] (FF) Methohexital;
3 [(FF)] (GG) Methylphenobarbital (mephobarbital);
4 [(GG) Nemetazepam;]
5 (HH) Midazolam;
6 (II) Nimetazepam;
7 [(HH)] (JJ) Nitrazepam;
8 [(II)] (KK) Nordiazepam;
9 [(JJ)] (LL) Oxazepam;
10 [(KK)] (MM) Oxazolam;
11 [(LL)] (NN) Paraldehyde;
12 [(MM) Penazepam;]
13 [(NN)] (OO) Pentazocine;
14 [(OO)] (PP) Petrichloral;
15 [(PP)] (QQ) Phenobarbital;
16 (RR) Pinazepam;
17 [(QQ)] (SS) Prazepam;
18 [(RR)] (TT) Quazepam;
19 [(SS) Tempazepam;]
20 (UU) Temazepam;
21 [(TT)] (VV) Tetrazepam; [and]
22 [(UU) Treazolam.]
23 (WW) Triazolam; and
24 (XX) Zolpidem.
25 (iii) Any material, compound, mixture, or preparation of fenfluramine which contains any
26 quantity of the following substances, including its salts, isomers whether optical, position, or
27 geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers
28 is possible.
29 (iv) Unless specifically excepted or unless listed in another schedule, any material,
30 compound, mixture, or preparation which contains any quantity of the following substances having
31 a stimulant effect on the central nervous system, including its salts, isomers whether optical,

- 16 -

1 position, or geometric isomers, and salts of the isomers when the existence of the salts, isomers,
2 and salts of isomers is possible within the specific chemical designation:
3 (A) Cathine ((+)-norpseudoephedrine);
4 (B) Diethylpropion;
5 (C) Fencamfamine;
6 (D) Fenproprex;
7 (E) [Mazidole] Mazindol;
8 (F) Mefenorex;
9 [(H)] (G) Pemoline, including organometallic complexes and chelates thereof;
10 [(G)] (H) Phentermine;
11 (I) Pipradrol; and
12 (J)SPA[((-)-1-climethylamino-1,2 diphenylethane)]
13 ((-)-1-dimethylamino-1,2-diphenylethane).
14 (v) Unless specifically excepted or unless listed in another schedule, any material,
15 compound, mixture, or preparation which contains any quantity of dextropropoxyphene
16 (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
17 (e) Schedule V: Any compound, mixture, or preparation containing any of the following
18 limited quantities of narcotic drugs, or their salts [of any of them] calculated as the free anhydrous
19 base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
20 sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
21 qualities other than those possessed by the narcotic drug alone:
22 (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
23 (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
24 (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
25 (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
26 atropine sulfate per dosage unit;
27 (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
28 (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine
29 sulfate per dosage unit; [and]
30 (vii) unless specifically exempted or excluded or unless listed in another schedule, any
31 material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant effect

- 17 -

1 on the central nervous system, including its salts, isomers, and salts of isomers[.]; and
2 (viii) unless specifically excepted or unless listed in another schedule, any material,
3 compound, mixture, or preparation containing any Buprenorphine and its salts.
4 Section 2. Informational note.
5 The symbols used in this bill do not appear in the electronic version. Please refer to the
6 hard copy version on file with the Utah House of Representatives or the Office of Legislative
7 Printing to view these symbols.




Legislative Review Note
as of 1-23-98 12:13 PM

A limited legal review of this bill raises no obvious constitutional or statutory concerns.

Office of Legislative Research and General Counsel

- 18 -